SSA
GMDA

Schonfeld Strategic Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,400
Closed -$18K – 3138
2022
Q3 		$18K Buy
+11,400
New +$26K ﹤0.01% 2717

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet Tel Aviv, Israel $506M AUM 21.19% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Schonfeld Strategic Advisors's GMDA Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q4 2022, closing a stake of 11,400 shares — an estimated $18K sold.

Schonfeld Strategic Advisors first reported a position in GMDA in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 55 funds tracked by Wall St. Rank hold GMDA as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,400 Gamida Cell Ltd. Ordinary Shares shares in Q4 2022, an estimated $18K.
  • Schonfeld Strategic Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $18K in Q3 2022.
  • 55 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.